Table 1 Baseline characteristics of the patient population at hospital admission
Age (years), mean (CI95%) | 67.3 (64.8–69.9) |
Sex | |
Men, n (%) | 85 (55.56) |
Women, n (%) | 68 (44.44) |
Comorbidities | |
Arterial hypertension, n (%) | 79 (51.63) |
Dyslipidaemia, n (%) | 61 (39.87) |
Type 2 diabetes mellitus, n (%) | 38 (24.84) |
Atrial fibrillation, n (%) | 20 (13.07) |
Ischaemic heart disease, n (%) | 24 (15.69) |
Heart failure, n (%) | 13 (8.50) |
Chronic kidney disease, n (%) | 15 (9.80) |
Cerebrovascular accident, n (%) | 11 (7.19) |
Active smoker, n (%) | 7 (4.58) |
Chronic obstructive pulmonary disease, n (%) | 12 (7.84) |
Asthma, n (%) | 15 (9.80) |
Chronic liver disease, n (%) | 5 (3.27) |
Charlson index (not age adjusted), mean (CI95%) | 1.87 (1.42–2.32) |
Severity | |
CURB65, mean (CI95%) | 1.29 (1.15–1.44) |
Oximetric and analytic parameter | Mean (CI95%) |
SpO2/FiO2 | 423.3 (412.8–433.8) |
Creatine (mg/dL) | 1.10 (0.99–1.20) |
Aspartate aminotransferase (U/L) | 52 (38–66) |
Alanine aminotransferase (U/L) | 62 (37–88) |
Gamma-glutamyl transpeptidase(U/L) | 76 (61–92) |
Alkaline phosphatase (IU/L) | 85 (76–94) |
Sodium (mmol/L) | 138 (137–139) |
Potassium (mmol/L) | 4 (3.9–4) |
Leukocytes (× 106/L) | 7509 (6469–8550) |
Platelets (× 106/L) | 207,650 (194,819–220,482) |
Lymphocytes, total (× 106/L) | 1612 (786–2439) |
d-dimers (ng/mL) | 1535 (899–2170) |
Lactate dehydrogenase (U/L) | 311 (291–331) |
C-reactive protein (mg/dL) | 19.74 (3.87–35.60) |
Clinical manifestations of SARS-CoV-2 infected patients | |
Fever, n (%) | 84 (54.9) |
Dyspnoea, n (%) | 95 (62.09) |
Cough, n (%) | 113 (73.85) |
Expectoration, n (%) | 27 (17.64) |
Fatigue, n (%) | 44 (28.75) |
Diarrhoea, n (%) | 29 (18.95) |
Myalgia, n (%) | 35 (22.87) |
Ageusia, n (%) | 2 (1.3) |
Anosmia, n (%) | 1 (0.65) |